Susquehanna Fundamental Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,184
| Closed | -$661K | – | 991 |
|
|
2025
Q1 | $661K | Buy |
+20,184
| New | +$661K | 0.01% | 782 |
|
|
2024
Q2 | – | Sell |
-15,899
| Closed | -$542K | – | 1011 |
|
|
2024
Q1 | $542K | Buy |
+15,899
| New | +$542K | 0.03% | 453 |
|
|
2023
Q2 | – | Sell |
-47,212
| Closed | -$1.71M | – | 856 |
|
|
2023
Q1 | $1.71M | Sell |
47,212
-8,396
| -15% | -$304K | 0.04% | 416 |
|
|
2022
Q4 | $1.98M | Sell |
55,608
-4,230
| -7% | -$151K | 0.03% | 484 |
|
|
2022
Q3 | $2.03M | Buy |
+59,838
| New | +$2.03M | 0.03% | 572 |
|
|
2022
Q1 | $581K | Buy |
+17,986
| New | +$581K | 0.01% | 1013 |
|
|
2021
Q3 | – | Sell |
-16,588
| Closed | -$511K | – | 1884 |
|
|
2021
Q2 | $511K | Sell |
16,588
-11,866
| -42% | -$366K | 0.01% | 1156 |
|
|
2021
Q1 | $745K | Buy |
28,454
+15,409
| +118% | +$403K | 0.01% | 999 |
|
|
2020
Q4 | $328K | Sell |
13,045
-3,455
| -21% | -$86.9K | 0.01% | 1248 |
|
|
2020
Q3 | $344K | Buy |
16,500
+1,000
| +6% | +$20.8K | 0.01% | 1012 |
|
|
2020
Q2 | $368K | Buy |
+15,500
| New | +$368K | 0.02% | 691 |
|